Who invested in Monte Rosa Therapeutics

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$300Mraised across 1 round since 2026, from 1 source

Latest round: Round, $300MJan 2026
Investors: 6

See who backed them

The rounds

Jan 2026
Round$300M
Source recorded

Founders and team

From Monte Rosa Therapeutics's own website: 7 on the team.

Markus WarmuthChief Executive Officer
Filip JankuChief Medical Officer
Jennifer ChampouxChief Operating Officer
John CastleChief Data and Information Officer
Magnus WalterChief Technology Officer
Phil NicksonChief Business and Legal Officer
Sharon TownsonChief Scientific Officer

AdvisersChandra P. Leo

Everyone who backed them

New Enterprise AssociatesVC firm1round

FidelityVC firm1round

BlackRockAsset manager1round

Versant VenturesVC firm1round

Cormorant Asset ManagementPrivate equity1round

RTW Investments LLCGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Monte Rosa Therapeutics

Who invested in Monte Rosa Therapeutics?

Monte Rosa Therapeutics's investors include New Enterprise Associates, Fidelity, BlackRock, Versant Ventures and Cormorant Asset Management, and 1 more on record.